Acne Among Japanese Patients with Atopic Dermatitis Receiving Upadacitinib in the Phase 3 Rising Up Study

被引：0

作者：

Nobukazu Hayashi

Masanori Ikeda

John Liu

Eliza Raymundo

Yingyi Liu

Takuya Sasaki

Kenshi Yamasaki

机构：

[1] Toranomon Hospital,Department of Dermatology

[2] Okayama University School of Medicine,Department of Dermatology

[3] AbbVie Inc.,Department of Pediatrics

[4] AbbVie GK,undefined

[5] Tohoku University Graduate School of Medicine,undefined

[6] Fukuyama Municipal Hospital,undefined

[7] Rifu Dermatology and Allergology Clinic,undefined

来源：

Dermatology and Therapy | 2023年 / 13卷

关键词：

Acne vulgaris; Atopic dermatitis; Eczema; Janus kinase inhibitors; Randomized controlled trial; Safety; Upadacitinib;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1817 / 1830

页数：13

共 50 条

[1] Acne Among Japanese Patients with Atopic Dermatitis Receiving Upadacitinib in the Phase 3 Rising Up Study
Hayashi, Nobukazu
Ikeda, Masanori
Liu, John
Raymundo, Eliza
Liu, Yingyi
Sasaki, Takuya
Yamasaki, Kenshi
[J]. DERMATOLOGY AND THERAPY, 2023, 13 (08) : 1817 - 1830
[2] Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study
Norito Katoh
Masanori Ikeda
Yukihiro Ohya
Hiroyuki Murota
Xiaofei Hu
John Liu
Hayato Niiyama
Takuya Sasaki
Eliza M. Raymundo
Hidehisa Saeki
[J]. Dermatology and Therapy, 2024, 14 : 213 - 232
[3] Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study
Katoh, Norito
Ikeda, Masanori
Ohya, Yukihiro
Murota, Hiroyuki
Hu, Xiaofei
Liu, John
Niiyama, Hayato
Sasaki, Takuya
Raymundo, Eliza M.
Saeki, Hidehisa
[J]. DERMATOLOGY AND THERAPY, 2024, 14 (01) : 213 - 232
[4] Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study
Katoh, Norito
Ohya, Yukihiro
Murota, Hiroyuki
Ikeda, Masanori
Hu, Xiaofei
Ikeda, Kimitoshi
Liu, John
Sasaki, Takuya
Raymundo, Eliza M.
Teixeira, Henrique D.
Saeki, Hidehisa
[J]. DERMATOLOGY AND THERAPY, 2023, 13 (01) : 221 - 234
[5] Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study
Norito Katoh
Yukihiro Ohya
Hiroyuki Murota
Masanori Ikeda
Xiaofei Hu
Kimitoshi Ikeda
John Liu
Takuya Sasaki
Eliza M. Raymundo
Henrique D. Teixeira
Hidehisa Saeki
[J]. Dermatology and Therapy, 2023, 13 : 221 - 234
[6] Etiological Insights of Acne in Atopic Dermatitis Patients under Upadacitinib Treatment: An Exploratory Study
Muzy, Guilherme
[J]. SKIN PHARMACOLOGY AND PHYSIOLOGY, 2024,
[7] Open Growth analysis among adolescents with moderate-to-severe atopic dermatitis receiving upadacitinib in combination with topical corticosteroids in Japan: A case study series from a phase 3, randomized, controlled trial (Rising Up)
Tanaka, Toshiaki
Sasaki, Takuya
Ikeda, Kimitoshi
Liu, Jianzhong
Tenorio, Allan R.
Ohya, Yukihiro
[J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2022, 15 (09):
[8] Effectiveness of upadacitinib in Japanese patients with prurigo-type atopic dermatitis: Four cases report
Kosaka, Keiji
Uchiyama, Akihiko
Ishikawa, Mai
Motegi, Sei-ichiro
[J]. JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (06) : 262 - 263
[9] Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis
Ono, Ryosuke
Yagi, Michio
Shoji, Akinobu
Fujita, Kayo
Yoshida, Mizuki
Ports, William C.
Purohit, Vivek S.
[J]. JOURNAL OF DERMATOLOGY, 2020, 47 (01): : 25 - 32
[10] UPADACITINIB VERSUS DUPILUMAB IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF THE HEADS UP PHASE 3 TRIAL
Blauvelt, Andrew
Teixeira, Henrique D.
Simpson, Eric L.
Costanzo, Antonio
De Bruin-Weller, Marjolein
Barbarot, Sebastien
Prajapati, Vimal H.
Lio, Peter
Hu, Xiaofei
Wu, Tianshuang
Liu, John
Ladizinski, Barry
Chu, Alvina D.
Eyerich, Kilian
[J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 62 - 62

← 1 2 3 4 5 →